1. Home
  2. GSM vs AKBA Comparison

GSM vs AKBA Comparison

Compare GSM & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSM
  • AKBA
  • Stock Information
  • Founded
  • GSM 2015
  • AKBA 2007
  • Country
  • GSM United Kingdom
  • AKBA United States
  • Employees
  • GSM 3283
  • AKBA N/A
  • Industry
  • GSM Metal Mining
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GSM Basic Materials
  • AKBA Health Care
  • Exchange
  • GSM Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • GSM 841.7M
  • AKBA 729.1M
  • IPO Year
  • GSM N/A
  • AKBA 2014
  • Fundamental
  • Price
  • GSM $4.09
  • AKBA $2.00
  • Analyst Decision
  • GSM Hold
  • AKBA Strong Buy
  • Analyst Count
  • GSM 1
  • AKBA 6
  • Target Price
  • GSM N/A
  • AKBA $6.25
  • AVG Volume (30 Days)
  • GSM 1.7M
  • AKBA 4.7M
  • Earning Date
  • GSM 11-05-2025
  • AKBA 11-10-2025
  • Dividend Yield
  • GSM 1.36%
  • AKBA N/A
  • EPS Growth
  • GSM N/A
  • AKBA N/A
  • EPS
  • GSM N/A
  • AKBA N/A
  • Revenue
  • GSM $1,373,244,000.00
  • AKBA $203,733,000.00
  • Revenue This Year
  • GSM N/A
  • AKBA $53.38
  • Revenue Next Year
  • GSM $18.61
  • AKBA $30.53
  • P/E Ratio
  • GSM N/A
  • AKBA N/A
  • Revenue Growth
  • GSM N/A
  • AKBA 16.75
  • 52 Week Low
  • GSM $2.97
  • AKBA $1.52
  • 52 Week High
  • GSM $5.74
  • AKBA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • GSM 30.30
  • AKBA 29.04
  • Support Level
  • GSM $4.68
  • AKBA $2.07
  • Resistance Level
  • GSM $5.18
  • AKBA $3.19
  • Average True Range (ATR)
  • GSM 0.21
  • AKBA 0.16
  • MACD
  • GSM -0.13
  • AKBA -0.09
  • Stochastic Oscillator
  • GSM 11.20
  • AKBA 1.24

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's business segments include North America- Silicon, North America -Silicon Alloys; Europe Manganese; Europe Silicon Metals; Europe -Silicon Alloys, South Africa Silicon Metals, South Africa-Silicon Alloys, and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: